China's Hanyuan Biotechnology: It is expected that the annual net loss will be between 195 million and 237 million yuan in 2025, a decrease from the previous year.

According to the announcement of He Yuan Biotech, it is expected that the net profit attributable to the owners of the parent company in 2025 will be between -2.37 billion yuan and -1.95 billion yuan, a decrease of 84.813 million yuan to 1.27 billion yuan compared to the same period last year, with a decrease rate of 26.35% to 39.41%; it is expected to achieve a net profit attributable to the owners of the parent company after deducting non-recurring gains and losses of -2.44 billion yuan to -2.01 billion yuan, a decrease of 91.9124 million yuan to 1.35 billion yuan compared to the same period last year, with a decrease rate of 27.36% to 40.16%.